224
submitted 7 months ago by Five@slrpnk.net to c/news@beehaw.org
you are viewing a single comment's thread
view the rest of the comments
[-] Kajo@beehaw.org 15 points 7 months ago

Before being an appetite suppressant, it is a medication for diabetes.

The problem is not the margin Novo Nordisk makes on an appetite suppressant, contrary to what the headline says.

The twofold problem is the margin on a diabetes drug, which weighs heavily on patients and health insurers around the world. And the potential supply problems for diabetics, when a vital drug is sold as a miracle weight-loss remedy.

this post was submitted on 30 Mar 2024
224 points (100.0% liked)

World News

22057 readers
50 users here now

Breaking news from around the world.

News that is American but has an international facet may also be posted here.


Guidelines for submissions:

These guidelines will be enforced on a know-it-when-I-see-it basis.


For US News, see the US News community.


This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago
MODERATORS